Characterization of macrophage - Cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Hollmén, Maija ^a   Roudnicky, Filip ^a   Karaman, Sinem ^a   Detmar, Michael ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; ESTROGEN RECEPTOR;

BREAST TUMOR; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; COCULTURE; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLISM; MONOCYTE; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST CANCER; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; COCULTURE TECHNIQUES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION MEDIATORS; MACROPHAGE ACTIVATION; MACROPHAGES; MONOCYTES; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84924970188     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09188     Document Type: Article

References (46)

1. Noy, R. & Pollard, J. W. Tumor-associated macrophages: from mechanisms to therapy. Immunity 41, 49-61 (2014).
2. Mantovani, A., Biswas, S. K., Galdiero, M. R., Sica, A. & Locati, M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 229, 176-185 (2013).
3. Movahedi, K. et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res 70, 5728-5739 (2010).
4. Mantovani, A. & Sica, A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 22, 231-237 (2010).
5. Erreni, M.,Mantovani, A. & Allavena, P. Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer. Cancer Microenviron 4, 141-154 (2011).
6. Funada, Y. et al. Prognostic significance of CD81 T cell and macrophage peritumoral infiltration in colorectal cancer. Oncol Rep 10, 309-313 (2003).
7. Piras, F. et al. The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase. Cancer 104, 1246-1254 (2005).
8. Hanada, T. et al. Prognostic value of tumor-associated macrophage count in human bladder cancer. Int J Urol 7, 263-269 (2000).
9. Lissbrant, I. F. et al. Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival. Int J Oncol 17, 445-451 (2000).
10. Ohno, S. et al. Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer. Anticancer Res 24, 3335-3342 (2004).
11. Hamada, I. et al. Clinical effects of tumor-associated macrophages and dendritic cells on renal cell carcinoma. Anticancer Res 22, 4281-4284 (2002).
12. Leek, R. D. et al. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56, 4625-4629 (1996).
13. Mahmoud, S.M. et al. Tumour-infiltrating macrophages and clinical outcome in breast cancer. J Clin Pathol 65, 159-163 (2012).
14. Ueno, T. et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 6, 3282-3289 (2000).
15. Qian, B. Z. et al. CCL2 recruits inflammatory monocytes to facilitate breasttumour metastasis. Nature 475, 222-225 (2011).
16. Lin, E. Y., Nguyen, A. V., Russell, R. G. & Pollard, J. W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193, 727-740 (2001).
17. Boyle, P. Triple-negative breast cancer: epidemiological considerations and recommendations. Ann Oncol 23 Suppl 6, vi7-12 (2012).
18. Crown, J., O'Shaughnessy, J. & Gullo, G. Emerging targeted therapies in triplenegative breast cancer. Ann Oncol 23 Suppl 6, vi56-65 (2012).
19. El Hadri, K. et al. Thioredoxin-1 promotes anti-inflammatory macrophages of the M2 phenotype and antagonizes atherosclerosis. Arterioscler Thromb Vasc Biol 32, 1445-1452 (2012).
20. West, N. R., Murray, J. I. & Watson, P. H. Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer. Oncogene 33, 1485-1494 (2014).
21. Komori, T., Tanaka, M., Senba, E., Miyajima, A. & Morikawa, Y. Lack of oncostatin M receptor b leads to adipose tissue inflammation and insulin resistance by switching macrophage phenotype. J Biol Chem 288, 21861-21875 (2013).
22. Marotta, L. L. et al. The JAK2/STAT3 signaling pathway is required for growth of CD441CD242 stem cell-like breast cancer cells in human tumors. J Clin Invest 121, 2723-2735 (2011).
23. Li, N. Y. et al.Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype. J Am Coll Surg 217, 17-26; discussion 26 (2013).
24. Teng, M. W. et al.Opposing roles for IL-23 and IL-12 in maintaining occult cancer in an equilibrium state. Cancer Res 72, 3987-3996 (2012).
25. Kim, S. et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457, 102-106 (2009).
26. Chow, A. et al. Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-kB. Sci Rep 4, 5750 (2014).
27. McWhorter, F. Y., Wang, T., Nguyen, P., Chung, T. & Liu, W. F. Modulation of macrophage phenotype by cell shape. Proc Natl Acad Sci U S A 110, 17253-17258 (2013).
28. Fukumura, D. & Jain, R. K. Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancer Metastasis Rev 17, 77-89 (1998).
29. Green, S. J., Crawford, R. M., Hockmeyer, J. T., Meltzer, M. S. & Nacy, C. A. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. J Immunol 145, 4290-4297 (1990).
30. Klug, F. et al. Low-dose irradiation programs macrophage differentiation to an iNOS1/M1 phenotype that orchestrates effective T cell immunotherapy. Cancer Cell 24, 589-602 (2013).
31. Cameron, D. J. & Churchill, W. H. Cytotoxicity of human macrophages for tumor cells. Enhancement by human lymphocyte mediators. J Clin Invest 63, 977-984 (1979).
32. Loberg, R. D. et al. CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration. Neoplasia 9, 556-562 (2007).
33. Patsialou, A. et al. Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor. Cancer Res 69, 9498-9506 (2009).
34. Su, S. et al. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell 25, 605-620 (2014).
35. Algars, A. et al. Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients. Int J Cancer 131, 864-873 (2012).
36. Pulaski, B. A. et al. Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanism. Cancer Res 53, 2112-2117 (1993).
37. Frendl, G. & Beller, D. I. Regulation of macrophage activation by IL-3. I. IL-3 functions as a macrophage-activating factor with unique properties, inducing Ia and lymphocyte function-associated antigen-1 but not cytotoxicity. J Immunol 144, 3392-3399 (1990).
38. Yu, C. F., Hong, J.H. & Chiang, C. S. The roles of macrophages and nitric oxide in interleukin-3-enhanced HSV-Sr39tk-mediated prodrug therapy. PLoS One 8, e56508 (2013).
39. Di Rosa, M. et al. Immuno-modulatory effects of vitamin D3 in humanmonocyte and macrophages. Cell Immunol 280, 36-43 (2012).
40. Bruce, D., Yu, S., Ooi, J. H. & Cantorna, M. T. Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. Int Immunol 23, 519-528 (2011).
41. Grugan, K. D. et al. Tumor-associated macrophages promote invasion while retaining Fc-dependent anti-tumor function. J Immunol 189, 5457-5466 (2012).
42. Medrek, C., Pontén, F., Jirström, K. & Leandersson, K. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer 12, 306 (2012).
43. Lehmann, B. D. et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 121, 2750-2767 (2011).
44. Li, R. et al. SOAP2: an improved ultrafast tool for short read alignment. Bioinformatics 25, 1966-1967 (2009).
45. Audic, S. & Claverie, J. M. The significance of digital gene expression profiles. Genome Res 7, 986-995 (1997).
46. Kim, K. I. & van de Wiel, M. A. Effects of dependence in high-dimensional multiple testing problems. BMC Bioinformatics 9, 114 (2008).